rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Asit Parikh

Director

Company insider

Files Form 4 as: Director, Phathom Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
48
Buys
11
Sells
0
Bought
$390K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
21 May 2021
Last trade
22 May 2026
Last filed
27 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
PHAT Phathom PharmaceuticalsDirector · Biotechnology · last 22 May 202611 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
02Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
22 May 2026filed 27 May 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code G—28,000 at $0.00filing
22 May 2026filed 27 May 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code G—28,000 at $0.00filing
22 May 2026filed 27 May 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code G—28,000 at $0.00filing
22 May 2026filed 27 May 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code G—28,000 at $0.00filing
20 May 2026filed 21 May 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code M$87K17,500 at $4.95filing
20 May 2026filed 21 May 2026PHAT Phathom Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—17,500 at $0.00filing
20 May 2026filed 21 May 2026PHAT Phathom Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—17,500 at $0.00filing
20 May 2026filed 21 May 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code M$87K17,500 at $4.95filing
19 May 2026filed 21 May 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code A—24,122 at $0.00filing
19 May 2026filed 21 May 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code A—24,122 at $0.00filing
10 Mar 2026filed 11 Mar 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code G—40,000 at $0.00filing
10 Mar 2026filed 11 Mar 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code G—40,000 at $0.00filing
10 Mar 2026filed 11 Mar 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code G—40,000 at $0.00filing
10 Mar 2026filed 11 Mar 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code G—40,000 at $0.00filing
23 Jan 2026filed 27 Jan 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code G—80,500 at $0.00filing
23 Jan 2026filed 27 Jan 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code G—80,500 at $0.00filing
23 Jan 2026filed 27 Jan 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code G—80,500 at $0.00filing
23 Jan 2026filed 27 Jan 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code G—80,500 at $0.00filing
13 Jan 2026filed 15 Jan 2026PHAT Phathom PharmaceuticalsBiotechnologySEC FORM 4 Code M$90K8,750 at $10.30filing
13 Jan 2026filed 15 Jan 2026PHAT Phathom Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—8,750 at $0.00filing

Sectors

Health Care11

Buys in green, sells in red, by the company’s sector.

Related people

Sanjeev NarulaChief Financial & Bus. Officer · Chief Financial & Bus. Officer at Phathom Pharmaceuticals, filing Form 4 there in the last year
Robert Charles BreedlovePrincipal Accounting Officer · Principal Accounting Officer at Phathom Pharmaceuticals, filing Form 4 there in the last year
Frank KarbeDirector · Director at Phathom Pharmaceuticals, filing Form 4 there in the last year
James N. TopperDirector and 10% owner · Director and 10% owner at Phathom Pharmaceuticals, filing Form 4 there in the last year
Heidi FieldsDirector · Director at Phathom Pharmaceuticals, filing Form 4 there in the last year